Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Erratum.

16:04 EDT 24th July 2014 | BioPortfolio

Summary of "Erratum."

Erratum Murthy et al., "The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats" Diabetes & Vascular Disease Research 2010 7(2):138-144. In the above paper the Acknowledgments section was printed incorrectly. It should have read: Acknowledgements Supported by Lilly - Amylin and, in part, by NIH grants HL62000, and HL77421. Dr Fonseca is also supported by NIH clinical trials (ACCORD and TINSAL-T2D) and by a grant from the American Diabetes Association and the Tullis Tulane Alumni Chair in Diabetes.

Affiliation

Journal Details

This article was published in the following journal.

Name: Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease
ISSN: 1752-8984
Pages:

Links

Clinical Trials [0 Results]

None

Medical and Biotech [MESH] Definitions

Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Article